General Information of the Compound
Compound ID
CP0511217
Compound Name
4-tert-butyl-N-quinolin-5-yl-1,3-thiazol-2-amine
    Show/Hide
Synonyms
CHEMBL207857
N-(4-tert-butylthiazol-2-yl)quinolin-5-amine
SCHEMBL14433246
    Show/Hide
Structure
Formula
C16H17N3S
Molecular Weight
283.4
Canonical SMILES
CC(C)(C)c1csc(Nc2cccc3ncccc23)n1
    Show/Hide
InChI
InChI=1S/C16H17N3S/c1-16(2,3)14-10-20-15(19-14)18-13-8-4-7-12-11(13)6-5-9-17-12/h4-10H,1-3H3,(H,18,19)
    Show/Hide
InChIKey
RGBQNFYMCAUMHK-UHFFFAOYSA-N
Physicochemical Property
logP
4.7324
Rotatable Bonds
2
Heavy Atom Count
20
Polar Areas
37.81
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
20

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9900444
SID: 14869292
ChEMBL ID
CHEMBL207857
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01508, C-C chemokine receptor type 4
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000108 CCRF-CEM Homo sapiens (Human)  1
1
IC50 = 300 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( N-(4-tert-butylthiazol-2-yl)quinolin-5-amine )
Drug Name N-(4-tert-butylthiazol-2-yl)quinolin-5-amine
Target(s)
C-C chemokine receptor type 4 (CCR4)
Inhibitor